US 9227918
Short acting phenylalkylamine calcium channel blockers and uses thereof
granted A61KA61K31/216A61K31/26
Quick answer
US patent 9227918 (Short acting phenylalkylamine calcium channel blockers and uses thereof) held by Milestone Pharmaceuticals Inc. expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Milestone Pharmaceuticals Inc.
- Grant date
- Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/216, A61K31/26, A61K31/275, A61K31/277